The cardiac biomarker testing market covers the revenue generated from the sales of kits, instruments, and consumables used in the cardiac diagnostic procedures. The revenue generated from the sales of commercialized cardiac biomarker testing is also covered in this report. However, the application of biomarkers in clinical trials, research, drug validation, drug development, risk assessment, and drug formulation is excluded from the scope of this report. The report also excludes the revenue generated from the services provided by the physicians in the cardiac diagnostics procedures.

CHAPTER 1: INTRODUCTION 

CHAPTER 2: EXECUTIVE SUMMARY 

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: CARDIAC BIOMARKER TESTING MARKET, BY BIOMARKER TYPE 

CHAPTER 5: CARDIAC BIOMARKER TESTING MARKET, BY APPLICATION

CHAPTER 6: CARDIAC BIOMARKER TESTING MARKET, BY LOCATION OF TESTING

CHAPTER 7: CARDIAC BIOMARKER TESTING MARKET, BY REGION

CHAPTER 8: COMPANY PROFILES